GDTC News

Three small issuers began trading this past week, two of which are eligible for inclusion in our IPO stats, while two delayed to the week ahead (UCAR and USGO). Four IPOs submitted initial filings, led by one biotech and one reinsurer both planning to raise $100 million. Chinese amusement and water park operator Golden Heaven Group (GDHG) downsized and priced...read more

CytoMed Therapeutics, a Singaporean preclinical biotech developing gamma-delta T cell therapies for cancer, raised $10 million by offering 2.4 million shares at $4, the low end of the range of $4 to $5. ...read more

Updated Monday, 4/10. Three companies are currently scheduled to list in the week ahead, two of which are eligible for inclusion in our IPO stats. Other small deals may also join the calendar to price during the week. While there are no sizable deals currently on the calendar, several in the pipeline have provided recent updates ahead of potential April launches. This...read more

CytoMed Therapeutics, a Singaporean preclinical biotech developing gamma-delta T cell therapies for cancer, announced terms for its IPO on Wednesday. The Singapore-based company plans to raise $11 million by offering 2.4 million shares at a price range of $4 to $5. At the midpoint of the proposed range, CytoMed Therapeutics would command a fully diluted market value of $51 million....read more